Today: 1 May 2026
Strategy Inc (MSTR) stock slides 5% as Clear Street cuts target; MSCI decision nears
9 January 2026
1 min read

Strategy Inc (MSTR) stock slides 5% as Clear Street cuts target; MSCI decision nears

NEW YORK, Jan 9, 2026, 14:32 EST — Regular session

  • Strategy shares slip about 5% as bitcoin nudges lower
  • Clear Street cuts its price target to $268, sticks with “buy”
  • Investors focus on MSCI conclusions due Jan. 15, with early-February earnings also in view

Strategy Inc shares slid about 5% Friday afternoon, underperforming a rising market after an analyst cut a price target on the bitcoin-linked software company. The stock fell $8.52 to $158.45. Bitcoin eased 0.9% to about $90,217, while the Nasdaq-tracking QQQ ETF was up about 1.1%.

Strategy’s stock can swing wildly because the company has hitched its balance sheet to bitcoin. Strategy, formerly MicroStrategy, calls itself a bitcoin treasury company — it holds bitcoin as its primary treasury reserve asset and has financed purchases through capital markets alongside its software business.

Clear Street analyst Brian Dobson on Friday cut his price target on Strategy to $268 from $443, while sticking with a buy rating, after dialing back his bitcoin-price and treasury-yield assumptions. He wrote the stock still offers “a differentiated” route to leveraged bitcoin exposure on a per-share basis even after dilution, and said MSCI’s recent stance on crypto treasury firms lowered the risk of forced selling by index funds. Investing.com

The MSCI debate has hung over the stock. “It removes a material near-term technical risk,” said Owen Lau, an analyst at Clear Street, after MSCI shelved — for now — a proposal to exclude “digital asset treasury companies,” firms that hold crypto tokens on their balance sheets, from major indexes. Mike O’Rourke, chief market strategist at JonesTrading, said he suspected the exclusion was “postponed until later in the year” as MSCI considers broader rules. Reuters

A filing earlier this week underscored why investors often trade Strategy like a bitcoin proxy. In an 8-K dated Jan. 5, Strategy said it bought 1,286 bitcoin between Dec. 29 and Jan. 4 for about $116.3 million, lifting holdings to 673,783 bitcoins as of Jan. 4. The company said it funded the purchases with proceeds from its at-the-market, or ATM, share-sale program — a method for selling stock into the open market.

MSCI’s consultation on digital-asset treasury companies is due to wrap up with final conclusions on Jan. 15, according to an MSCI announcement. Any changes that follow would be taken up in the February 2026 index review. For Strategy, the rulebook matters: benchmark inclusion can drive passive-fund buying and selling, and the stock’s volatility can magnify those flows.

Other crypto-linked names were mixed on Friday. Coinbase slid about 1.8%, Marathon Digital was down 1.7% and Riot Platforms added 1.5%.

The bear case isn’t hard to map out. If bitcoin sells off harder, Strategy’s reported results take a hit, and it gets tougher to raise fresh money without heavy dilution. And if index rules tighten, incremental demand from passive investors could still be capped.

MSCI’s next call is due Jan. 15, and Strategy is expected to report quarterly results in early February. Nasdaq data points to Feb. 4 as the next earnings date.

Stock Market Today

  • SanDisk Q3 Beats Expectations Amid Finite NAND Pricing Cycle
    May 1, 2026, 5:22 AM EDT. SanDisk reported phenomenal Q3 results, beating sales estimates by 20% and earnings by 50%. The company's gains are driven by supply constraints in NAND memory chips amid heightened AI demand, leading to soaring prices and exceptional profitability, with incremental gross margins above 90%. However, analysts caution that this pricing surge is finite, forecasting a supply glut in 2027-2028 from increased manufacturing capacity by SanDisk and competitors like SK Hynix and Samsung. This anticipated supply increase may trigger a sharp price correction, impacting SanDisk's future sales and profits despite ongoing AI demand. Investors should weigh short-term gains against longer-term risks of a down cycle.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 01.05.2026

1 May 2026
LIVEMarkets rolling coverageStarted: May 1, 2026, 12:00 AM EDTUpdated: May 1, 2026, 5:29 AM EDT SanDisk Q3 Beats Expectations Amid Finite NAND Pricing Cycle May 1, 2026, 5:22 AM EDT. SanDisk reported phenomenal Q3 results, beating sales estimates by 20% and earnings by 50%. The company's gains are driven by supply constraints in NAND memory chips amid heightened AI demand, leading to soaring prices and exceptional profitability, with incremental gross margins above 90%. However, analysts caution that this pricing surge is finite, forecasting a supply glut in 2027-2028 from increased manufacturing capacity by SanDisk and competitors like SK Hynix and
Sandisk Stock Falls After Blowout Q3 Earnings as AI Storage Rally Hits a High Bar

Sandisk Stock Falls After Blowout Q3 Earnings as AI Storage Rally Hits a High Bar

1 May 2026
Sandisk shares dropped about 6% in after-hours trading Thursday despite reporting fiscal Q3 revenue of $5.95 billion, up 251% from a year earlier, and net income of $3.62 billion. The company announced a $6 billion buyback and forecast Q4 revenue of up to $8.25 billion. Gross margin rose to 78.4%. Shares had closed at $1,096.51 before slipping to about $1,030.
Apple Stock Slips After Earnings Beat as iPhone Supply Snag Clouds $100 Billion Buyback

Apple Stock Slips After Earnings Beat as iPhone Supply Snag Clouds $100 Billion Buyback

1 May 2026
Apple reported fiscal Q2 revenue of $111.2 billion and earnings of $2.01 per share, beating analyst estimates. The board approved a $100 billion share buyback and raised the dividend. Shares fell about 1% after hours as iPhone sales missed forecasts and chip supply remained tight. Investors are watching for clarity on AI strategy and the upcoming CEO transition to John Ternus.
Revolution Medicines stock rises as Merck buyout talks swirl; FDA designation adds another spark
Previous Story

Revolution Medicines stock rises as Merck buyout talks swirl; FDA designation adds another spark

HealthEquity stock slides after Goldman Sachs downgrade; HQY earnings watch shifts to March
Next Story

HealthEquity stock slides after Goldman Sachs downgrade; HQY earnings watch shifts to March

Go toTop